References
Bergman, K. & Graff, G.D. Nat. Biotechnol. 25, 419–424 (2007).
Mathews, D.J., Graff, G.D., Saha, K. & Winickoff, D.E. Science 331, 725–727 (2011).
Scott, C.T., McCormick, J.B., DeRouen, M.C. & Owen-Smith, J. Cell 145, 820–826 (2011).
Caulfield, T., Ogbogu, U., Murdoch, C. & Einsiedel, E. Regen. Med. 3, 483–496 (2008).
Walsh, J.P., Cho, C. & Cohen, W.M. Science 309, 2002–2003 (2005).
Golden, J.M. J. Law Med. Ethics 38, 314–331 (2010).
Scott, C.T., McCormick, J.B. & Owen-Smith, J. Nat. Biotechnol. 27, 696–697 (2009).
Scott, C.T., McCormick, J.B., DeRouen, M.C. & Owen-Smith, J. Nat. Methods 7, 866–867 (2010).
Thomson, J.A. et al. Science 282, 1145–1147 (1998).
Winickoff, D.E., Saha, K. & Graff, G.D. Yale J. Health Policy Law Ethics 9, 52–127 (2009).
Streiffer, R. Hastings Cent. Rep. 38, 40–47 (2008).
Karmali, R.N., Jones, N.M. & Levine, A.D. Nat. Biotechnol. 28, 1246–1248 (2010).
Acknowledgements
The author acknowledges financial support provided by the Roadmap for an Entrepreneurial Economy Program, supported by the Georgia Research Alliance and the Kauffman Foundation, as well as support from Georgia Tech. The author also acknowledges research assistance from R. Karmali, pre-testing assistance from T. McDevitt's group, and helpful comments on a draft of this article from J. Walsh, all at Georgia Tech.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Tables 1–3 (PDF 119 kb)
Rights and permissions
About this article
Cite this article
Levine, A. Access to human embryonic stem cell lines. Nat Biotechnol 29, 1079–1081 (2011). https://doi.org/10.1038/nbt.2029
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2029
- Springer Nature America, Inc.